<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03063320</url>
  </required_header>
  <id_info>
    <org_study_id>PKE Spice PP</org_study_id>
    <nct_id>NCT03063320</nct_id>
  </id_info>
  <brief_title>The Effect of Spice Consumption on Postprandial Vascular Function</brief_title>
  <official_title>The Effect of Chronic Consumption of Popular Spices on Postprandial Vascular Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Penn State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A 3-period randomized cross-over, controlled feeding study will be conducted to determine the
      effect of chronic spice consumption on postprandial vascular function. Participants will
      consume three test diets containing different amounts of spice. Each treatment period will
      last for 4 weeks. After each diet period a meal test will be conducted. Participants will
      consume a meal with a spice content corresponding to the diet period they have just
      completed. Endothelial function will be measured at 2 and 4 hours after meal consumption.
      Blood samples will also be taken during the 4 hours after meal consumption for measurement of
      lipids, immune and inflammatory markers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A 3-period randomized cross-over, controlled feeding study will be conducted to determine the
      effect of chronic spice consumption on postprandial vascular function, lipid levels, immune
      and inflammatory markers. Participants will consume three test diets containing different
      amounts of spice. Each treatment period will last for 4 weeks. At baseline and after each
      diet period a postprandial test will be conducted. Flow mediated dilation (FMD) will
      conducted in the fasting state and a catheter will be inserted for blood sampling.
      Participants will consume a control test meal containing low spice at baseline and after each
      diet period the test meal will contain a level of spice that corresponds to the amount of
      spice consumed during the diet period. Blood samples will be taken at 30, 60, 120, 180 and
      240 minutes after meal consumption, and FMD will be performed at 120 and 240 minutes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 25, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>3 period randomized cross over</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Person assessing the outcome measures will be blinded to participant allocation</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in flow mediated dilation</measure>
    <time_frame>Change from baseline at 2 hours and 4 hours after meal consumption</time_frame>
    <description>Endothelial function measured by FMD</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lipid and lipoproteins</measure>
    <time_frame>Change from baseline during the 4 hours after meal consumption</time_frame>
    <description>Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma Inflammatory cytokines</measure>
    <time_frame>Change from baseline during the 4 hours after meal consumption</time_frame>
    <description>Serum: IL-1β, IL-6, IL-10, IL-12p70, interferon-gamma, monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha, TNF-alpha, vascular endothelial growth factor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory cytokines in isolated peripheral blood mononuclear cells</measure>
    <time_frame>Change from baseline during the 4 hours after meal consumption</time_frame>
    <description>TNF-alpha, IL-6,NF-κB, I-κB, MAP kinase, COX-2, iNOS from stimulated and unstimulated lipopolysaccharides in peripheral blood mononuclear cells. Activation status of macrophages.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>Change from baseline during the 4 hours after meal consumption</time_frame>
    <description>Plasma glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>Change from baseline during the 4 hours after meal consumption</time_frame>
    <description>Plasma insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma antioxidants</measure>
    <time_frame>Change from baseline during the 4 hours after meal consumption</time_frame>
    <description>hydrophilic ORAC, lipophilic ORAC, total ORAC</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cardiovascular Risk Factor</condition>
  <arm_group>
    <arm_group_label>Low Spice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The test meal (~1200kcal and 44g fat) will contain ~0.6g of spice blend</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate Spice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The test meal (~1200kcal and 44g fat) will contain ~3.7g of spice blend</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Culinary Spice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The test meal (~1200kcal and 44g fat) will contain ~7.4g of spice blend</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spice blend</intervention_name>
    <description>Test spices include cardamom, coriander, cumin, ginger, paprika, red pepper, turmeric, cinnamon</description>
    <arm_group_label>Low Spice</arm_group_label>
    <arm_group_label>Moderate Spice</arm_group_label>
    <arm_group_label>Culinary Spice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Men and postmenopausal women Overweight or obese (25-35kg/m2) Non-smoking Waist
        circumference &gt;= 94cm for men and &gt;=80cm for women

        At least one other of the following:

          -  LDL- cholesterol &gt;130mg/dL

          -  CRP &gt;1mg/L

          -  Triglycerides &gt;=150mg/dL

          -  HDL &lt;40mg/dL for men or &lt;50mg/dL for women

          -  Systolic blood pressure &gt;= 130mmHg or diastolic &gt;= 85mmHg

          -  Fasting glucose &gt;=100mg/dL

        Exclusion Criteria:

          -  Diabetes (fasting glucose &gt;126mg/dL)

          -  Hypertension (systolic blood pressure &gt;160mmHg or diastolic blood pressure &gt;100mmHg)

          -  Prescribed anti-hypertensive or glucose lowering drugs

          -  Established cardiovascular disease, stroke, diabetes, liver, kidney or autoimmune
             disease

          -  Use of cholesterol/lipid lowering medication or supplementation (psyllium, fish oil,
             soy lecithin, phytoestrogens) and botanicals

          -  Pregnancy or lactation

          -  Weight loss of &gt;=10% of body weight within the 6 months prior to enrolling in the
             study

          -  Vegetarianism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Penny M Kris-Etherton, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penn State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristina S Petersen, PhD</last_name>
    <phone>814-863-8622</phone>
    <email>kup63@psu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer Fleming</last_name>
    <phone>814-863-8056</phone>
    <email>jas@psu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Penn State University</name>
      <address>
        <city>University Park</city>
        <state>Pennsylvania</state>
        <zip>16802</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina S Petersen, PhD</last_name>
      <phone>814-863-8622</phone>
      <email>kup63@psu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Fleming</last_name>
      <phone>814-863-8056</phone>
      <email>jas@psu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Connie J Rogers, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sheila G West, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2017</study_first_submitted>
  <study_first_submitted_qc>February 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2017</study_first_posted>
  <last_update_submitted>January 15, 2018</last_update_submitted>
  <last_update_submitted_qc>January 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Penn State University</investigator_affiliation>
    <investigator_full_name>Penny Kris-Etherton</investigator_full_name>
    <investigator_title>Distinguished Professor of Nutrition</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

